Skip to main content

Open Access 03.05.2024 | Original Communication

Evaluation of a multimodal diagnostic algorithm for prediction of cognitive impairment in elderly patients with dizziness

verfasst von: K. Felfela, N. Jooshani, K. Möhwald, D. Huppert, S. Becker-Bense, F. Schöberl, R. Schniepp, F. Filippopulos, M. Dieterich, M. Wuehr, A. Zwergal

Erschienen in: Journal of Neurology

Abstract

Background

The current diagnostic workup for chronic dizziness in elderly patients often neglects neuropsychological assessment, thus missing a relevant proportion of patients, who perceive dizziness as a subjective chief complaint of a concomitant cognitive impairment. This study aimed to establish risk prediction models for cognitive impairment in chronic dizzy patients based on data sources routinely collected in a dizziness center.

Methods

One hundred patients (age: 74.7 \(\pm\) 7.1 years, 41.0% women) with chronic dizziness were prospectively characterized by (1) neuro-otological testing, (2) quantitative gait assessment, (3) graduation of focal brain atrophy and white matter lesion load, and (4) cognitive screening (MoCA). A linear regression model was trained to predict patients’ total MoCA score based on 16 clinical features derived from demographics, vestibular testing, gait analysis, and imaging scales. Additionally, we trained a binary logistic regression model on the same data sources to identify those patients with a cognitive impairment (i.e., MoCA < 25).

Results

The linear regression model explained almost half of the variance of patients’ total MoCA score (R2 = 0.49; mean absolute error: 1.7). The most important risk-predictors of cognitive impairment were age (β = − 0.75), pathological Romberg’s sign (β = − 1.05), normal caloric test results (β = − 0.8), slower timed-up-and-go test (β = − 0.67), frontal (β = − 0.6) and temporal (β = − 0.54) brain atrophy. The binary classification yielded an area under the curve of 0.84 (95% CI 0.70–0.98) in distinguishing between cognitively normal and impaired patients.

Conclusions

The need for cognitive testing in patients with chronic dizziness can be efficiently approximated by available data sources from routine diagnostic workup in a dizziness center.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1007/​s00415-024-12403-3.
K. Felfela and N. Jooshani contributed equally.

Introduction

Current classifications of vestibular disorders almost exclusively list peripheral neuro-otological disorders such as bilateral vestibulopathy as a cause of chronic dizziness [1, 2], while central or higher vestibular network pathologies are implicated less often [3]. Accordingly, routine workup of dizzy patients presently focusses on quantification of function of peripheral vestibular afferents and reflexes (such as the vestibulo-ocular reflex). However, especially in an elderly population, a relevant proportion of dizzy patients has no sufficient explanation of their symptoms based on peripheral vestibular function tests only. Recently, a syndrome called Dizziness in Cognitive Impairment (DCI) was shown to account for up to one third of cases with chronic dizziness in patients above the age of 60 years [4]. In this syndrome, a specific presumably neurodegenerative pattern with a selective effect on parieto-insular multisensory vestibular and cognitive networks was identified as the potential pathophysiological correlate. Several previous studies have reported a prevalence of dizziness of 30–50% in patients with various dementia syndromes [5, 6]. Despite this obvious interrelation, the simultaneous appraisal of dizziness and cognitive impairment in clinical route diagnostics is often neglected [6, 7]. The primary reasons for this shortcoming may be firstly that routine cognitive screening of elderly dizzy patients might be too time-consuming and secondly that there are to date no validated questionnaires or rating scales available, which are sufficiently sensitive to detect both vestibular and cognitive complaints [7].
A potential solution for this drawback may be to combine data sources from clinical routine testing to establish prediction models for cognitive impairment in chronic dizziness. The most promising candidates are likely demographic factors (mostly age) [8], vestibular function testing [9], gait and posture assessment, as well as neuroimaging [4]. Studies in age cohorts, for example, were able to link measurements of postural stability and gait with cognitive function and even neurodegenerative alterations [10, 11]. Growing evidence indicates that cognitively impaired patients display an altered gait pattern including reduced speed especially in dual-task conditions as well as an increased variability of time-related gait parameters [11]. These gait pattern changes can even precede cognitive decline and are therefore considered as early risk markers for dementia [12].
The main aim of the current study was thus to assess the predictive value of routine data sources, such as demographic parameters, vestibular tests, gait and posture assessment, as well as neuroimaging separately and in combination, for the prediction of cognitive function and impairment in patients with chronic dizziness. Using this approach, we aimed to identify readily available risk markers for cognitive dysfunction in patients with chronic dizziness, which should indicate the need for a dedicated follow-up neuropsychological testing. This could help to improve current standards of practice in the differential diagnosis of elderly patients with chronic dizziness.

Materials and methods

Participants and study design

In this prospective cohort study, 100 patients (age > 60 years, age: 74.7 ± 7.1 years, 41.0% women), who presented to the German Center for Vertigo and Balance Disorders (LMU Munich, Germany) with the chief complaint of chronic dizziness, vertigo or balance disorders (thereafter referred to under the umbrella term “dizziness”, detailed symptoms in supplement), were recruited consecutively over a period of 3 months and were thoroughly characterized by (1) neuro-otological examination (including video head impulse testing (vHIT), caloric testing, Romberg’s test); (2) in-laboratory quantitative gait assessment (GAITRite® sensor carpet, functional gait assessment—FGA, timed-up-and-go test—TUG); (3) grading of routine brain magnetic resonance (MR) or computer tomography (CT) images regarding white matter lesion load and focal brain atrophy using established visual rating scales; and (4) Montreal Cognitive Assessment (MoCA) score as a cognitive screening test (Fig. 1). Neuro-otological diagnoses were made following the established International Classification of Vestibular Disorders (ICVD) for unilateral or bilateral vestibulopathy, Menière's disease, benign paroxysmal positional vertigo, vestibular paroxysmia, and vestibular migraine [1].

Neuro-otological testing

Experienced technicians conducted horizontal vHIT testing using a lightweight video-oculography device (EyeSeeCam®, Fürstenfeldbruck, Germany) with an integrated digital high-speed camera. The vHIT gain was calculated as a ratio of eye per head acceleration at 60 ms to evaluate the function of the vestibulo-ocular reflex (VOR) in the high-frequency range. Additionally, for caloric testing both ears’ external auditory canals were irrigated once with 20 ml cold (30 °C) and once with 20 ml warm (44 °C) water. The maximum slow phase velocity (mSPV in °/s) of caloric nystagmus was determined to quantify VOR function in the low-frequency range. A stabilometer platform was used to conduct the posturographic examination (Kistler®, Winterthur, Switzerland) in accordance with previously established protocols [13]. The Romberg’s quotient (RQ) (i.e., the ratio of postural sway path with eyes closed to that with eyes open) was then calculated in anterior–posterior (AP) and medio-lateral (ML) axes, and was considered pathological if the ratio in any of the two axes was \(\ge\) 2 [14]. Alternatively, in patients without a posturography analysis (n = 42), an increase of body sway in Romberg’s test with eyes closed was clinically rated as pathological by experienced neuro-otologists. Ocular and cervical vestibular evoked myogenic potentials (oVEMPs and cVEMPs) were not performed routinely.

Quantitative gait analysis

Gait patterns were assessed using a 6.7 m long pressure-sensitive gait carpet (GAITRite®, CIR Systems, Havertown, USA) with a sampling frequency of 120 Hz during walking at preferred speed and during walking with a cognitive dual task (serial 7). Patients walked in total four times across the carpet in each gait condition to collect enough strides for further analysis. Additionally, cognitive dual task costs during walking were evaluated as follows: first, by the percentage change of speed during dual task walking compared to single task walking (locomotor costs), and second, by the change of frequency for correct numerical operations during dual task walking vs. sitting (cognitive costs). For the timed-up-and-go (TUG) test, patients were seated on a chair and asked to stand up on verbal command, walk 3 m, turn around, walk back to the chair and sit down. All subjects also received a functional gait assessment (FGA) consisting of a 10-item clinical gait performance evaluation with an overall score ranging from 0 to 30, with 30 being the best possible score.

Neuroimaging: visual rating scales

In the routine brain MR- or CT-images, white matter lesion load and focal brain atrophy were assessed using the following established visual rating scales: the FAZEKAS scale for cerebral microvascular lesions (0–3) [15], the global cortical atrophy—frontal scale (GCA-F) (0–3), mesiotemporal atrophy (MTA)-scale (0–4), KOEDAM-scale for parieto-occipital atrophy (0–3) [16, 17], the insula opercular atrophy (IOA) scale (0–3) [4]. Focal brain atrophy was dichotomized for further data analysis into normal and abnormal based on suggestions from previous studies, i.e. scores of ≥ 2 in GCA-F, KOEDAM, IOA or MTA-scale (for patients < 75 years) and scores of ≥ 3 in MTA-scale (for patients ≥ 75 years) [1820]. In the same way, FAZEKAS grades ≥ 2 were interpreted as abnormal [21].

Neuropsychological tests and symptom questionnaires

A standardized neuropsychological screening test using MoCA was performed with all participants. Patients with total MoCA scores < 25 were classified as cognitively impaired [22]. The Beck Depression Inventory II (BDI-II) [23], the European Quality of Life-5 Dimensions-5 Levels (EQ-5D-5L) questionnaire [24], and the Dizziness Handicap Inventory (DHI) [25] were assessed to evaluate the potential effect of confounders such as depression, perceived health-related disability and symptom severity on cognitive performance.

Statistical analysis

Descriptive statistics and univariate analysis using a combination of parametric (i.e., ANCOVA and Student’s t test) and non-parametric tests (i.e., Quade- and Chi2-tests) were performed in SPSS (Version 27.0, IBM Corp., USA) to test for differences in clinical features between cognitively impaired (MoCA < 25) and normal patients. Age was considered as a covariate to control for age differences between both groups. Normal distribution was assessed using Q–Q plot diagrams and histograms. Results were considered significant at p < 0.05. In general, only patients with a complete data set were included in the final analysis. For single missing data (about 1% of all data) multiple imputation was applied.
Linear and logistic regression was performed to generate models for the prediction of cognitive function and impairment (i.e., MoCA score) or a classification of cognitively impaired vs. normal patients, respectively. Regression analysis was done using python programming language Version 3.8 and the open-source module scikit-learn for statistical testing and machine learning. Linear regression with regularization was performed using Least Absolute Shrinkage and Selection Operator (LASSO), which penalizes the regression model via L1-norm and in effect shrinks the effect of non-contributing features to zero. A tenfold nested cross-validation (CV) was performed for model selection and hyperparameter tuning. The complete dataset was initially split into training (80%) and test (20%) sets. Starting from the training set, the outer CV measured the performance of each model, while the inner was used to tune the model hyperparameters by minimizing the mean squared error (MSE) in each fold of the outer CV. The model with the best performance (i.e., minimum MSE) was then trained on the whole training set in a tenfold CV and its performance was assessed on the remaining test set.
Logistic regression with L2-norm regularization was performed for binary classification of cognitively impaired vs. normal patients. Model performance was tested using a tenfold CV and evaluated by the area-under-the-curve (AUC) of a receiver-operating-characteristic (ROC). Binary classification models were trained and evaluated separately for 4 different feature sets (demographics, clinical vestibular testing, gait parameters, imaging parameters) as well as for the entire feature set (age, gender, cardiovascular risk factors (CVRF), Romberg sign, caloric excitability, vHIT gain, preferred speed, dual task speed costs, cognitive costs, TUG, FGA, FAZEKAS, GCA-F, MTA, KOEDEM, IOA scale).

Results

Patient characteristics and clinical features

While the cognitively impaired group was older than the cognitively healthy group (p < 0.001, Student’s t test), no significant differences were observed regarding other collected demographic features (Table 1). Neuro-otological diagnoses as defined by ICVD (see methods) were significantly more prevalent in the group of patients with MoCA ≥ 25 (Table 1). Peripheral vestibular results, with the exception of the left-sided vHIT gain, differed significantly across the two cognitive groups (mean mSPV right/left: p = 0.03/p = 0.04, vHIT gain right/left: p = 0.017/p = 0.268, ANCOVA, vHIT refixation saccades: p = 0.028) and tended to be lower towards higher MoCA scores. Patients with cognitive dysfunction also displayed more pronounced balance deficits compared to the cognitively normal group (p = 0.017, Chi-square test) (Table 2). The two groups, however, did not differ regarding either walking speed in preferred and dual task conditions or dual task locomotor and cognitive costs (p ≥ 0.06, ANCOVA). Cognitively impaired subjects took longer to perform the TUG test and scored less in the FGA than cognitively normal patients (p = 0.03, p = 0.023, respectively, ANCOVA). Imaging markers also indicated a higher prevalence of pathological cortical atrophy for all lobes and white matter lesion load towards lower MoCA scores (p ≤ 0.008, Chi-square test) (see Fig. 2 and Table 2).
Table 1
Comparison of demographics and clinical neuro-otological diagnoses among MoCA groups
 
MoCA < 25 (n = 45)
MoCA \(\ge\) 25 (n = 55)
p value
Agea
77.7 \(\pm\) 5.0
72.3 \(\pm\) 7.6
 < 0.001*
Gender Fb
35.6%
45.5%
0.599
CVRFc
1 \(\pm\) 1
1 \(\pm\) 2
0.356
Neuro-otological diagnosisb
31.1%
54.5%
0.034*
 Acute unilateral peripheral vestibulopathy
13.3%
14.5%
0.447
 Bilateral vestibulopathy
8.9%
25.5%
0.070
 Menière's disease
0%
3.6%
0.069
 Vestibular migraine
4.4%
3.6%
0.570
 Benign paroxysmal positional vertigo
4.4%
7.3%
0.705
 Vestibular schwannoma
0%
5.4%
0.068
*p < 0.05
aMean \(\pm\) standard deviation, Student’s t test (two-sided p value)
bFrequencies, Chi-square test
cMedian \(\pm\) interquartile (IQ) range, Quade test. Multiple diagnoses were possible
Table 2
Comparison of patients’ vestibular testing, in-laboratory gait assessment, imaging markers, across MoCA groups
 
MoCA < 25 (n = 45)
MoCA \(\ge\) 25 (n = 55)
p value
Vestibular testinga,b,c
 Average caloric excitability (in °/s)a
17.8 \(\pm\) 10.5
15.0 \(\pm\) 10.0
0.031*
 Right ear mean caloric response (in °/s)a
15.8 \(\pm\) 10.0
13.2 \(\pm\) 10.4
0.030*
 Left ear mean caloric response (in °/s)a
19.6 \(\pm\) 11.5
16.3 \(\pm\) 11.3
0.040*
 vHIT gain righta
93.0 \(\pm\) 25.2
80.3 \(\pm\) 30.1
0.017*
 vHIT gain lefta
91.1 \(\pm\) 25.5
84.0 \(\pm\) 31.6
0.268
 vHIT refixation saccades totalb
5 (11.1%)
18 (32.7%)
0.028*
 RQ in ML-axisb
1.16 \(\pm\) 2.03 (n = 23)
0.74 \(\pm\) 0.94 (n = 34)
0.083
 RQ in AP-axisb
1.02 \(\pm\) 1.25 (n = 23)
1.00 \(\pm\) 0.72 (n = 35)
0.349
 Pathological Romberg’s signc
66.7%
38.2%
0.017*
In-laboratory quantitative gait assessmenta
 PS: velocity (in m/s)
0.78 \(\pm\) 0.18
0.91 \(\pm\) 0.22
0.060
 DTC: velocity (in m/s)
0.57 \(\pm\) 0.18
0.68 \(\pm\) 0.25
0.248
 Costs: locomotor
− 27.2 \(\pm\) 16.3
− 24.7 \(\pm\) 21.8
0.841
 Costs: cognitive
− 30.68 \(\pm\) 30.94
− 19.88 \(\pm\) 27.91
0.349
 TUG
10.14 \(\pm\) 3.74
8.29 \(\pm\) 3.25
0.030*
 FGA
19.44 \(\pm\) 4.61
22.20 \(\pm\) 4.64
0.023*
Imagingd
 FAZEKAS
48.9%
34.5%
0.002*
 Mean GCA-F
44.4%
23.6%
 < 0.001*
 Mean KOEDAM
46.7%
36.4%
0.008*
 Mean MTA
37.8%
14.5%
0.006*
 Mean IOA
84.4%
60%
 < 0.001*
*Marks significant results
aMean \(\pm\) standard deviation, ANCOVA
bMedian \(\pm\) interquartile range, Quade-test
cFrequencies, Chi2 test
dFrequencies of pathological white matter lesion load (i.e., FAZEKAS ≥ 2) and pathological brain lobe atrophy, Chi2 test

Prediction models

Considering all available clinical features in a binary logistic regression model yielded an AUC of 0.84 (95% CI 0.70–0.98) in distinguishing between MoCA groups < 25 and ≥ 25. Solely considering features from the demographics category yielded an AUC of 0.70 (95% CI 0.50–0.90), from the clinical vestibular testing category an AUC of 0.70 (95% CI 0.56–0.84), from the gait assessment category an AUC of 0.66 (95% CI 0.48–0.84), and from the brain imaging category an AUC of 0.71 (95% CI 0.56–0.86) (Fig. 3A).
All 16 clinical features from the four assessment categories (i.e., demographics, vestibular tests, gait analysis and brain imaging) with at least three features per category were included to establish a linear regression model that should predict the total MoCA score of individual patients. The obtained linear model included 12 clinical features and yielded a R2 value of 0.49 with a mean absolute error (MAE) of 1.7 and thereby explained nearly 50% of cognitive variance in our cohort (Fig. 3B). Romberg’s sign, caloric response, age and TUG had the highest predictive value, while FAZEKAS, dual task cost cognitive, IOA and FGA had the lowest standardized coefficient values (Fig. 3C).

Discussion

Dizziness in Cognitive Impairment (DCI) has recently been described as a common syndrome in elderly patients with chronic dizziness, balance problems and instability of stance and gait [4]. However, testing for cognitive impairment is still often neglected in the current diagnostic algorithms for dizzy patients. Therefore, we aimed to establish a prediction model for cognitive function and impairment in elderly patients, based on commonly available clinical features from demographics, vestibular and gait assessment, as well as brain imaging. We demonstrate that prediction models considering features from all four routine assessment categories yielded a high and robust classification of cognitive impairment with an AUC of 0.84 \(\pm\) 0.14 and were able to explain about 50% of the cognitive variance in our patient cohort. We further show that considering clinical features from one routine assessment category only, considerably limits model performance. The proposed model could help to appropriately and efficiently select dizzy patients in need of neuropsychological testing and training.

Rationale behind the model feature selection

The machine learning approach in this study selected features well discussed for their potential in the prediction of the risk of cognitive decline. The parameters with a significant effect in the model ranked from highest to lowest predictive contribution are age > CVRF (demographics), Romberg’s sign > caloric response (vestibular), TUG > dual task cost velocity > FGA > dual task cost cognitive (gait) and GCA-F > MTA > IOA > FAZEKAS (imaging).
Demographic factors such as older age as well as CVRF are associated not only with vascular but also neurodegenerative dementia [2628]. Previous studies were able, for instance, to show the influence of older age on fluid cognition (i.e., the ability to process and learn new information and adapt to new circumstances) such as processing speed, working memory and executive cognitive function [8].
Vestibular contribution to cognitive functioning has been attracting increasing attention in recent years. For instance, brain networks involved in postural stability such as the cingulo-opercular, fronto-parietal, and somatosensory-motor networks are known to play a substantial role in normal cognitive performance [29]. Therefore, it is plausible that patients with morphological or vascular cortical pathologies within these shared brain networks not only exhibit a dynamic balance disturbance but also cognitive dysfunction, as shown in the recently described DCI syndrome [4]. Kido et al. for example, showed that postural instability is related to pathological cognitive decline and also neurodegenerative diseases [10]. In line with the recent study introducing the DCI syndrome [4], the degree of caloric response in the current study displayed a negative correlation with the MoCA scores (i.e., the lower the caloric response, the higher the MoCA scores). A possible explanation for this observation could be that lower caloric responses filter out patients with clear peripheral vestibular deficits leaving those with central pathologies, which in case of cortical affection of the multisensory vestibular processing network can also manifest with a concomitant cognitive dysfunction [4]. In addition, central pathologies may display a higher caloric response, based on disinhibition of cortico-cerebellar networks. At first sight, the finding of reduced peripheral vestibular function in cognitively unimpaired patients seems to partially contradict the previously reported deficits in visuo-spatial domains in patients with bilateral vestibulopathy [30]. However, these deficits in single cognitive subdomains are rather mild and may not be reflected optimally by MoCA screening. Importantly, the current study does not claim any causality between vestibular test results and the cognitive status, but only reports markers associated with presence of a cognitive impairment.
Gait patterns have also been shown to give insights into cognitive dysfunction and higher cortical and subcortical network pathologies [11]. A complex network of brain regions is involved in the control of locomotion and varies depending on gait speed and cognitive demand [31]. Cognitively impaired patients exhibit higher locomotor costs in dual-task conditions and an increased variability of time-related gait parameters [11]. These gait pattern changes even precede cognitive decline and might therefore be used as risk markers for early identification of dementia [12]. This condition has been previously termed motor cognitive risk syndrome [32]. The TUG test is also associated with cognitive functions, especially executive control, memory and processing speed [33]. Similarly, Pavlou et al. also depicted a correlation of cognitive function with FGA as well as dual task costs in chronic dizzy patients [34].
Brain imaging parameters such as focal cortical brain atrophy and white matter lesion load are well-known predictors for cognitive impairment [4]. Among the included visual atrophy scales, the GCA-F (addressing frontal lobe atrophy) is well-ascribed to higher cognitive functions including but not limited to language, working memory, problem solving, decision-making and behavior [35]. The MTA scale, on the other hand, assesses mesio-temporal atrophy, a well-established region for episodic and long-term memory and, more recently, for perception and attention [36]. There is also growing evidence highlighting the role of the insula in general cognitive functions such as language, perception, attention and working memory [4].

Comparison with other cognition prediction models

The prediction models from this study performed comparably and even superior to other previously reported algorithms in the risk prediction of cognitive impairment, although differences in patient collectives limit a direct comparison. A gait feature-based model for detecting cognitive dysfunction in the elderly utilizing a single wearable inertia sensor yielded an AUC of 0.73–0.88 [37]. A standardized evaluation of multiple cognition prediction algorithms based on imaging data showed that the best AUC achieved was about 0.79 [38]. In comparison, our study revealed an AUC of 0.66 for a combination of gait parameters and an AUC of 0.71 for a set of semi-quantitative white-matter lesion and atrophy imaging parameters (Fig. 3A). A recently proposed machine learning algorithm for detecting cognitive impairment based on multiple features reflecting demographic, clinical, psychological and lifestyle aspects achieved an AUC of 0.73–0.83 [39, 40]. In our binary logistic regression model, the combination of different feature categories resulted in a superior predictive value (AUC of 0.84). It should be noted that we applied features to the model, which were already available from routine data sources and could be quantified without major data preprocessing. The proposed models therefore should be suitable for application in a clinical setting of risk prediction. A combination of feature sources was superior to single feature source for our cohort.

Conclusions

The most important risk predictors of cognitive impairment in elderly dizzy patients, aside from the usual demographic factors, are postural instability, normal peripheral vestibular test results, impaired gait performance, higher frontal, insular and temporal focal brain atrophy, and white matter lesion load. We think that the proposed models may help clinicians to efficiently identify elderly patients with otherwise unexplained chronic dizziness at risk of DCI syndrome, to apply advanced cognitive testing for the differential diagnosis and appropriate neuropsychological training and drug treatment.

Acknowledgements

We thank Katie Göttlinger for copy-editing the manuscript.

Declarations

Conflicts of interest

The authors report no conflicts of interest related to the manuscript.

Ethical approval

This study was approved by the ethics committee of the Ludwig-Maximilians University, Munich (number: 414-15) and all patients gave their informed written consent for the pseudonymized use of their medical information for research goals.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Neuer Inhalt

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

Weitere Produktempfehlungen anzeigen
Anhänge

Supplementary Information

Below is the link to the electronic supplementary material.
Literatur
26.
Zurück zum Zitat Testai FD, Gorelick PB (2016) Vascular cognitive impairment and alzheimer disease: are these disorders linked to hypertension and other cardiovascular risk factors? In: Aiyagari V, Gorelick PB (eds) Hypertension and stroke: pathophysiology and management. Springer International Publishing, Cham, pp 261–284CrossRef Testai FD, Gorelick PB (2016) Vascular cognitive impairment and alzheimer disease: are these disorders linked to hypertension and other cardiovascular risk factors? In: Aiyagari V, Gorelick PB (eds) Hypertension and stroke: pathophysiology and management. Springer International Publishing, Cham, pp 261–284CrossRef
Metadaten
Titel
Evaluation of a multimodal diagnostic algorithm for prediction of cognitive impairment in elderly patients with dizziness
verfasst von
K. Felfela
N. Jooshani
K. Möhwald
D. Huppert
S. Becker-Bense
F. Schöberl
R. Schniepp
F. Filippopulos
M. Dieterich
M. Wuehr
A. Zwergal
Publikationsdatum
03.05.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-024-12403-3

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.